FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022249378> ?p ?o ?g. }

• W2022249378 endingPage "e214" @default.
• W2022249378 startingPage "e205" @default.
• W2022249378 abstract "Introduction This study aimed to assess the efficacy of anti–vascular endothelial growth factor receptor tyrosine kinase inhibitors (anti-VEGFR-TKIs) in patients with metastatic clear cell renal cell carcinoma (m-ccRCC) with sarcomatoid dedifferentiation. Patients and Methods The files of all patients with m-ccRCC consecutively treated with first-line anti-VEGFR-TKIs at the authors' institution were retrospectively reviewed. Pathology slides from nephrectomy and metastasectomy were assessed for the presence and extent of sarcomatoid dedifferentiation. Results A total of 124 patients were included; nephrectomy and metastasectomy specimens were available in 117 and 35 patients, respectively. Thirty percent of the primary nephrectomy specimens had sarcomatoid features, and the median involvement of the sarcomatoid component was 21% (range, 1%-95%). Patients with an important sarcomatoid component, defined as ≥ 25% involvement of the tumor, had a very poor outcome: progression-free survival (PFS) and overall survival (OS) were 3 and 6 months, respectively, and no partial responses (PR) were observed. Patients without sarcomatoid dedifferentiation or with sarcomatoid involvement < 25% had a PFS of 12 months (P < .0001; hazard ratio [HR], 51; 95% CI, 12.58-207.3), an OS of 22 months (P < .0001, HR, 10.72; 95% CI, 3.56-32.25), and a PR rate of 50% (P = .0015). Patients with a sarcomatoid component ≥ 25% in the metastasectomy also had a poorer PFS and OS on anti-VEGFR-TKIs compared with patients with < 25% of sarcomatoid features at these sites. Conclusion Patients with m-ccRCC whose tumors contain a component of sarcomatoid dedifferentiation of ≥ 25% of the total tumor volume have a very poor outcome when treated with anti-VEGFR-TKIs. Analysis of the extent of sarcomatoid features in resected metastases can provide additional prognostic information." @default.
• W2022249378 created "2016-06-24" @default.
• W2022249378 creator A5001188276 @default.
• W2022249378 creator A5014802766 @default.
• W2022249378 creator A5021550191 @default.
• W2022249378 creator A5025755353 @default.
• W2022249378 creator A5026692589 @default.
• W2022249378 creator A5028987367 @default.
• W2022249378 creator A5036213851 @default.
• W2022249378 creator A5048105550 @default.
• W2022249378 creator A5060616205 @default.
• W2022249378 creator A5063072327 @default.
• W2022249378 creator A5064190309 @default.
• W2022249378 creator A5082067671 @default.
• W2022249378 date "2014-10-01" @default.
• W2022249378 modified "2023-10-14" @default.
• W2022249378 title "Sarcomatoid Dedifferentiation in Metastatic Clear Cell Renal Cell Carcinoma and Outcome on Treatment With Anti–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: A Retrospective Analysis" @default.
• W2022249378 cites W1597277386 @default.
• W2022249378 cites W1931162541 @default.
• W2022249378 cites W1986910634 @default.
• W2022249378 cites W1999966467 @default.
• W2022249378 cites W2000552872 @default.
• W2022249378 cites W2016569548 @default.
• W2022249378 cites W2030709723 @default.
• W2022249378 cites W2031677302 @default.
• W2022249378 cites W2045778615 @default.
• W2022249378 cites W2048028114 @default.
• W2022249378 cites W2066085038 @default.
• W2022249378 cites W2081372483 @default.
• W2022249378 cites W2092804443 @default.
• W2022249378 cites W2099088585 @default.
• W2022249378 cites W2099752220 @default.
• W2022249378 cites W2118952669 @default.
• W2022249378 cites W2131444088 @default.
• W2022249378 cites W2147382551 @default.
• W2022249378 cites W2149456801 @default.
• W2022249378 cites W2155196945 @default.
• W2022249378 cites W2155688313 @default.
• W2022249378 cites W2157096649 @default.
• W2022249378 cites W2161797239 @default.
• W2022249378 cites W2162424705 @default.
• W2022249378 cites W2164584861 @default.
• W2022249378 cites W2164638888 @default.
• W2022249378 doi "https://doi.org/10.1016/j.clgc.2014.04.004" @default.
• W2022249378 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24861951" @default.
• W2022249378 hasPublicationYear "2014" @default.
• W2022249378 type Work @default.
• W2022249378 sameAs 2022249378 @default.
• W2022249378 citedByCount "34" @default.
• W2022249378 countsByYear W20222493782015 @default.
• W2022249378 countsByYear W20222493782016 @default.
• W2022249378 countsByYear W20222493782017 @default.
• W2022249378 countsByYear W20222493782018 @default.
• W2022249378 countsByYear W20222493782019 @default.
• W2022249378 countsByYear W20222493782020 @default.
• W2022249378 countsByYear W20222493782021 @default.
• W2022249378 countsByYear W20222493782022 @default.
• W2022249378 crossrefType "journal-article" @default.
• W2022249378 hasAuthorship W2022249378A5001188276 @default.
• W2022249378 hasAuthorship W2022249378A5014802766 @default.
• W2022249378 hasAuthorship W2022249378A5021550191 @default.
• W2022249378 hasAuthorship W2022249378A5025755353 @default.
• W2022249378 hasAuthorship W2022249378A5026692589 @default.
• W2022249378 hasAuthorship W2022249378A5028987367 @default.
• W2022249378 hasAuthorship W2022249378A5036213851 @default.
• W2022249378 hasAuthorship W2022249378A5048105550 @default.
• W2022249378 hasAuthorship W2022249378A5060616205 @default.
• W2022249378 hasAuthorship W2022249378A5063072327 @default.
• W2022249378 hasAuthorship W2022249378A5064190309 @default.
• W2022249378 hasAuthorship W2022249378A5082067671 @default.
• W2022249378 hasConcept C121608353 @default.
• W2022249378 hasConcept C126322002 @default.
• W2022249378 hasConcept C126894567 @default.
• W2022249378 hasConcept C142724271 @default.
• W2022249378 hasConcept C143998085 @default.
• W2022249378 hasConcept C207103383 @default.
• W2022249378 hasConcept C2777472916 @default.
• W2022249378 hasConcept C2777546739 @default.
• W2022249378 hasConcept C2778601017 @default.
• W2022249378 hasConcept C2779013556 @default.
• W2022249378 hasConcept C2779490328 @default.
• W2022249378 hasConcept C2780091579 @default.
• W2022249378 hasConcept C2780227381 @default.
• W2022249378 hasConcept C2780808757 @default.
• W2022249378 hasConcept C2781278892 @default.
• W2022249378 hasConcept C44249647 @default.
• W2022249378 hasConcept C71924100 @default.
• W2022249378 hasConceptScore W2022249378C121608353 @default.
• W2022249378 hasConceptScore W2022249378C126322002 @default.
• W2022249378 hasConceptScore W2022249378C126894567 @default.
• W2022249378 hasConceptScore W2022249378C142724271 @default.
• W2022249378 hasConceptScore W2022249378C143998085 @default.
• W2022249378 hasConceptScore W2022249378C207103383 @default.
• W2022249378 hasConceptScore W2022249378C2777472916 @default.
• W2022249378 hasConceptScore W2022249378C2777546739 @default.
• W2022249378 hasConceptScore W2022249378C2778601017 @default.
• W2022249378 hasConceptScore W2022249378C2779013556 @default.
• W2022249378 hasConceptScore W2022249378C2779490328 @default.

• next